NCT01577576

Brief Summary

The main objective of this study is to obtain data for the integrated analysis of morphological, functional and biomechanical parameters pertaining to lower limb arteries in various categories of elite athletes (without cardiovascular risk and practicing high- or low-impact aerobic activities which preferentially implicate lower limb activity) as compared to (each other and to) sedentary controls.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
56

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Sep 2012

Typical duration for all trials

Geographic Reach
1 country

2 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 12, 2012

Completed
4 days until next milestone

First Posted

Study publicly available on registry

April 16, 2012

Completed
5 months until next milestone

Study Start

First participant enrolled

September 1, 2012

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2015

Completed
Last Updated

November 30, 2015

Status Verified

November 1, 2015

Enrollment Period

2.5 years

First QC Date

April 12, 2012

Last Update Submit

November 27, 2015

Conditions

Keywords

AthletesSedentary volunteers

Outcome Measures

Primary Outcomes (1)

  • Presence / absence of intra parietal calcification of lower limb arteries

    Baseline (Day 0; transversal study)

Secondary Outcomes (48)

  • Extent of intra parietal calcification of lower limb arteries

    Baseline (Day 0; transversal study)

  • Inner diameter of the intima-media of the common femoral artery (mm)

    Baseline (Day 0; transversal study)

  • Outer diameter of the intima-media of the common femoral artery (mm)

    Baseline (Day 0; transversal study)

  • Inner diameter of the intima-media of the superficial femoral artery (mm)

    Baseline (Day 0; transversal study)

  • Outer diameter of the intima-media of the superficial femoral artery (mm)

    Baseline (Day 0; transversal study)

  • +43 more secondary outcomes

Study Arms (3)

Upper-body athletes

This group includes swimmers, rowers or kayakers with a history of at least 10 years of intense training, and performance in regional competitions for the past five years.

Lower-body athletes

This group includes runners (marathon or trail) and cyclists with a history of at least 10 years of intense training, and performance in regional competitions for the past five years.

Sedentary volunteers

This group of healthy volunteers does not participate in athletic activity for more than two hours per week. They are matched by age and sex with the athletic groups.

Eligibility Criteria

Age25 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

The study population is composed of three groups of healthy volunteers: (1) high impact lower-limb sports (marathon or trail); (2) low-impact lower-limb sports and (3) sedentary volunteers. All volunteers are between the ages of 25 and 40. The groups will be matched by age and sex. Athletic groups will be matched according to years of intensive practice and hours of training.

You may qualify if:

  • The volunteer must have given his/her informed and signed consent
  • The volunteer must be insured or beneficiary of a health insurance plan
  • Volunteers without cardiovascular disease, glucose regulation disorders or known renal disease
  • Ongoing athletic activity for the past 10 years
  • Athletic activity at the regional level for the past 5 years
  • Practices one of the three following sports: marathon, trail running, cycling.

You may not qualify if:

  • The volunteer is participating in another study
  • The volunteer is under judicial protection, under tutorship or curatorship
  • The volunteer refuses to sign the consent
  • It is impossible to correctly inform the volunteer
  • The volunteer is pregnant, parturient, or breastfeeding
  • Tobacco use
  • Contraindications for the practice of physical activity (joint, heart or other)
  • Intercurrent pathology
  • First degree family history of cardiovascular disease
  • Known dyslipidemia (including cholesterol)
  • Glucose tolerance abnormalities (prediabetes or diabetes)
  • Treatment with certain drugs used for treating erectile dysfunction: Sildefanil (Viagra), Tadalafil (Cialis), Vardenafil (Levitra) and yohimbine (Yohimbine Houde and Yocoral)
  • More than two hours of athletic activity per week
  • History of intense athletic training
  • Body mass index \>= 25 kg/m\^2

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Université d'Avignon, Faculté des Sciences

Avignon, 84000, France

Location

CHU de Nîmes - Hôpital Universitaire Carémeau

Nîmes, 30029, France

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

A non-fasting venous blood sample is required for the following cofactors: * serum protein * serum calcium * phosphorus * PTH * Vitamin D2 and D3 Left-over serum will be stored in the Nîmes University Hospital "Sérotheque" (serum collection).

MeSH Terms

Conditions

Monckeberg Medial Calcific Sclerosis

Condition Hierarchy (Ancestors)

Vascular CalcificationCalcinosisCalcium Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Study Officials

  • Antonia Perez Martin, MD

    Centre Hospitalier Universitaire de Nîmes

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 12, 2012

First Posted

April 16, 2012

Study Start

September 1, 2012

Primary Completion

March 1, 2015

Study Completion

March 1, 2015

Last Updated

November 30, 2015

Record last verified: 2015-11

Locations